Market Cap
$503.8M
XOMA
XOMA Royalty Corp
$162.79 ▼ -0.63%
Prev close $163.82Market cap$503.8M
12-mo target$39.00 (-2.9%)
High Impact Filing (7/10)11 New Institutional Positions9 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on XOMA right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Inst. Holders
50 funds
Inst. Value
$323.6M
Inst. Activity
11 buys / 9 sells
SEC Reports
5
Press Releases
3
Price chart 30d -0.8%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 11, 2026 earnings_calendar
Jul 27, 2026 SEC XOMA Q2 2026 Earnings Scheduled — 2026-08-11
XOMA Royalty Corp filed a Form 15-12G to terminate its SEC registration under Section 12(g), effective July 27, 2026. Th
15-12G — Impact 7/10
XOMA Royalty Corp. completed its acquisition by Ligand Pharmaceuticals on July 14, 2026. Common stockholders received $3
8-K — Impact 8/10
Jul 14, 2026 Insider
Montano Maricel Perea disposed of 65 shares
Chief Legal Officer
Jul 14, 2026 Insider
Montano Maricel Perea disposed of 37,074 shares
Chief Legal Officer
Jul 14, 2026 Insider
Montano Maricel Perea disposed of 11,316 shares
Chief Legal Officer
Jun 30, 2026 Inst.
Woodline Partners LP — ADD
1,114,363 shares ($47.4M)
Jun 30, 2026 Inst.
DIMENSIONAL FUND ADVISORS LP — ADD
177,106 shares ($7.5M)
Analyst ratings buy % -25.6%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Apr 30, 2026 | HC Wainwright & Co. | DOWNGRADE | Neutral | 43% |
| Mar 20, 2026 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Feb 24, 2026 | Leerink Partners | MAINTAIN | Outperform | 49% |
| Dec 11, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | 43% |
| Dec 11, 2025 | Leerink Partners | MAINTAIN | Outperform | 49% |
| Dec 9, 2025 | LUCID CAPITAL MARKETS | INITIATE | Buy | 36% |
| May 28, 2025 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Apr 17, 2025 | Benchmark | INITIATE | Buy | 54% |
| Mar 28, 2025 | HC Wainwright & Co. | REITERATE | Buy | 43% |
| Mar 19, 2025 | HC Wainwright & Co. | REITERATE | Buy | 43% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Aug 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Jul 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Jun 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| May 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Apr 1, 2026 | 3 | 6 | 2 | 0 | 0 | 82% | |
| Mar 1, 2026 | 3 | 6 | 2 | 0 | 0 | 82% | |
| Feb 1, 2026 | 3 | 6 | 1 | 0 | 0 | 90% |
Price targets
Where 1 covering analysts think XOMA trades over the next 12 months.
$39.00 -2.9% upside Hold
Current$40.17 Low$39.00 Median$39.00 High$39.00 1 analysts
$39.00$39.00
Analyst rating Hold· 3.0/5 as of Sep 13, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
5 SEC filing reports analyzed · 2 bullish, 1 bearish, 0 mixed, 2 neutral · avg impact 6.2/10.Plus 3 press releases.
BEARISH15-12G7/10
XOMA Royalty Corp filed a Form 15-12G to terminate its SEC registration under Section 12(g), effecti
Jul 27, 2026
BULLISH8-K8/10
XOMA Royalty Corp. completed its acquisition by Ligand Pharmaceuticals on July 14, 2026. Common stoc
Jul 14, 2026
BULLISHDEFA14A8/10
XOMA Royalty Corp filed additional definitive proxy soliciting materials (DEFA14A) confirming its ac
Jun 12, 2026
NEUTRAL8-K4/10
XOMA Royalty Corp announced that the previously announced acquisition by Ligand Pharmaceuticals is e
Jun 12, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 11, 2026
earnings_calendar
XOMA Q2 2026 Earnings Scheduled — 2026-08-11
Jul 15, 2026
listing_status
Delisted: XOMA — removed from the Nasdaq symbol directory
XOMA Royalty Corporation - Common Stock
Jul 15, 2026
trading_halt
Halt Resumed: XOMA — trading resumed after D (Security Deletion)
Halted 2026-07-13T23:50:00.000Z | Resumed 2026-07-15T04:00:01.000Z
Jul 15, 2026
ftd
FTD: XOMA — 978,061 shares ($39.3M) failed to deliver
Settlement: 20260715, Price: $40.17, FTD Value: $39,288,710.37, XOMA ROYALTY CORPORATION COMMO
Jul 14, 2026
ftd
FTD: XOMA — 978,042 shares ($39.3M) failed to deliver
Settlement: 20260714, Price: $40.17, FTD Value: $39,287,947.14, XOMA ROYALTY CORPORATION COMMO
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current FY | $0.55 | $0.55–$0.55 | -62.3% | +266.7% | 2↑ 1↓ | $0.1B | 1 |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current Q | $0.50 | $0.50–$0.50 | 13.6% | +185.7% | 0↑ 1↓ | $0.0B | 1 |
| Next Q | $0.52 | $0.52–$0.52 | -25.7% | +100.0% | 0↑ 1↓ | $0.0B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.500 | — |
| 7d ago | $0.175 | +0.325 |
| 30d ago | $0.175 | +0.325 |
| 60d ago | $0.175 | +0.325 |
| 90d ago | $0.228 | +0.272 |
Institutional ownership
Which big funds own XOMA (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $323.6M total value (7,617,885 shares) as of 2026-Q2. Top holders: MORGAN, FMR, Woodline. Net buying activity: 11 institutions added/increased vs 9 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| MORGAN STANLEY | 1,697,167 | $72.1M | 22.3% | — |
| FMR LLC | 1,605,532 | $68.2M | 21.1% | — |
| Woodline Partners LP | 1,114,363 | $47.4M | 14.6% | ADD +74.1% |
| BlackRock, Inc. | 691,971 | $29.4M | 9.1% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 505,165 | $21.5M | 6.6% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 245,321 | $10.4M | 3.2% | — |
| STATE STREET CORP | 197,764 | $8.4M | 2.6% | — |
| MILLENNIUM MANAGEMENT LLC | 196,307 | $8.3M | 2.6% | — |
| DIMENSIONAL FUND ADVISORS LP | 177,106 | $7.5M | 2.3% | ADD +32.8% |
| HSBC HOLDINGS PLC | 149,523 | $6.3M | 2.0% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| Woodline Partners LP | ADD | 640,001 | 1,114,363 | +74.1% | $47.4M |
| DIMENSIONAL FUND ADVISORS LP | ADD | 133,360 | 177,106 | +32.8% | $7.5M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | DOUBLED | 17,390 | 83,623 | +380.9% | $3.6M |
| JPMORGAN CHASE & CO | DOUBLED | 3,992 | 30,018 | +652.0% | $1.3M |
| CITADEL ADVISORS LLC | TRIM | 98,638 | 28,460 | -71.1% | $1.2M |
| UBS Group AG | TRIM | 72,533 | 23,843 | -67.1% | $1.0M |
| Nuveen, LLC | ADD | 12,706 | 18,388 | +44.7% | $781.5K |
| JANE STREET GROUP, LLC | ADD | 14,519 | 18,192 | +25.3% | $773.2K |
| WELLS FARGO & COMPANY/MN | DOUBLED | 3,865 | 8,495 | +119.8% | $361.0K |
| BANK OF AMERICA CORP /DE/ | TRIM | 11,018 | 6,878 | -37.6% | $292.3K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
8 insiders, 50 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | Montano Maricel Perea | Chief Legal Officer | J | 65 | — | — |
| Jul 14, 2026 | Montano Maricel Perea | Chief Legal Officer | D | 37,074 | — | — |
| Jul 14, 2026 | Montano Maricel Perea | Chief Legal Officer | D | 11,316 | — | — |
| Jul 14, 2026 | LIMBER JOSEPH M | Director | J | 9,532 | — | — |
| Jul 14, 2026 | LIMBER JOSEPH M | Director | D | 10,000 | — | — |
| Jul 14, 2026 | LIMBER JOSEPH M | Director | D | 20,000 | — | — |
| Jul 14, 2026 | LIMBER JOSEPH M | Director | D | 8,000 | — | — |
| Jul 14, 2026 | LIMBER JOSEPH M | Director | D | 2,366 | — | — |
| Jul 14, 2026 | LIMBER JOSEPH M | Director | D | 5,052 | — | — |
| Jul 14, 2026 | LIMBER JOSEPH M | Director | D | 8,167 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for XOMA.
Shares short
914,936
Settlement Jun 30, 2026
Change vs prior
+1.8%
Semi-monthly cycle
Days to cover
5.0
At avg daily volume
Of shares outstanding
≈7.3%
Estimate — not % of float
| Halted | Code | Reason | Status |
|---|---|---|---|
| Jul 13, 2026 | T12 | Info Requested | Not resumed |
| Jul 13, 2026 | D | Deletion | Resumed |
All XOMA filing & press-release reports (8)
- 15-12G reportJul 27, 2026
- 8-K reportJul 14, 2026
- DEFA14A reportJun 12, 2026
- 8-K reportJun 12, 2026
- PRESS-RELEASE reportMar 18, 2026
- 8-K reportMar 18, 2026
- PRESS-RELEASE reportMar 18, 2026
- PRESS-RELEASE reportMar 12, 2026